Ellevest’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Ellevest's NVS Position: Q3 2026 in Review
Ellevest reduced its Novartis (NVS) stake by 3.5% in Q3 2026, selling an estimated $66.3K and leaving 12,058 shares worth $1.7M. The position accounts for 0.2% of the portfolio, ranked #71.
Ellevest first reported a position in NVS in Q2 2019 and has held it in 30 quarters since. The position peaked at $2.1M in Q3 2024. 1,370 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Ellevest held 12,058 shares of Novartis worth $1.7M as of Q3 2026.
- Ellevest sold 437 Novartis shares in Q3 2026, an estimated $66.3K.
- Novartis made up 0.2% of Ellevest's portfolio in Q3 2026, its #71 holding.
- Ellevest first reported a position in Novartis in Q2 2019 and has held it in 30 quarters since.
- Ellevest's Novartis position peaked at $2.1M in Q3 2024.
- 1,370 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Ellevest's 13F filing for Q3 2026, filed 10 Nov 2026.